Skip Navigation
Section Navigation HPA website


 

Hybridoma Detail

Formats Price
£375.00
£525.00
£50.00

Hybridoma Collection: M290

Catalogue No.: 93012001
Cell Line Name: M290
Reactivity: Anti- alpha-E (alpha-M290) integrin subunit, mouse
Antibody Isotype: Rat IgG2a
Fusion Species: Mouse x Rat Hybridoma
Myeloma: P3X63Ag8.653
Immunological Donor: LOU/c rat spleen
Immunogen: Mouse gut intraepithelial lymphocytes
Transfected DNA: Not Applicable
Cell Line Description: No known cross reactivity. Blocks functional activity of mouse alpha-E-Beta-7 integrin.
Application: Functional studies on alpha-M290 ß7 in mice
Sub Culture Routine: Maintain cultures between 2-5x100,000 cells/ml; 5% CO2; 37°C.
Culture Medium: RPMI 1640 + 2mM glutamine + 10% Foetal Bovine Serum (FBS)
Depositor: Dr P Kilshaw, Babraham Institute, Babraham, Cambridge.
Originator: Yes
Country: UK
References: Immunol Lett 1988; 18:149; Eur J Immunol 1991; 20:2201; Eur J Immunol 1991; 21:2591; Eur J Immunol 1995;25:852
Patent: None Specified by Depositor
Research Council Deposit: Yes
Release Conditions: No

The HPA Culture Collections represent deposits of cultures from world-wide sources. While every effort is made to ensure details distributed by HPA Culture Collections are accurate, HPA Culture Collections cannot be held responsible for any inaccuracies in the data supplied. References where quoted are mainly attributed to the establishment of the cell culture and not for any specific property of the cell line, therefore further references should be obtained regarding cell culture characteristics. Passage numbers where given act only as a guide and HPA Culture Collections does not guarantee the passage number stated will be the passage number received by the customer.

Cultures supplied by HPA Culture Collections are for research purposes only. Enquiries regarding the commercial use of a cell line are referred to the depositor of the cell line. Some cell lines have additional special release conditions such as the requirement for a material transfer agreement to be completed by the potential recipient prior to the supply of the cell line. Please view the Terms & Conditions of Supply for more information.